Dr Triparna Sen speaks to ecancer in an online interview about novel immunotherapy approaches for the treatment of small cell lung cancer (SCLC).

She begins by giving a background into SCLC, which is the most aggressive form of lung cancer and describes the current landscape of the disease.

Dr Sen also explains her work in identifying therapeutic targets to treat SCLC, such as CHK1 and PARP. 

She concludes by discussing what the future looks like for immunotherapy as a treatment approach for SCLC.